Ridge Augmentation With Simultaneous Implant Placement Using Bone Blocks With Autogenous Tooth Graft

December 19, 2023 updated by: Dalia Rasheed Issa, Kafrelsheikh University

Ridge Augmentation With Simultaneous Implant Placement Using Xenogenic Blocks or Autogenous Bone Blocks With Autogenous Tooth Graft

Autogenous bone, with its osteogenic, osteoinductive, and osteo-conductive characteristics has been used for bone grafts with optimal integration into host tissues. For this reason, autogenous bone has been often considered the gold standard of bone regeneration material. However, the amount of autogenous bone that may be harvested is limited, and the harvesting procedure is traumatic.

Bone substitutes, including allografts, xenografts, and alloplasts have been used successfully as alternatives to autogenous bone grafts in ridge augmentation procedures.

In 2008, autogenous tooth bone graft (ATG) was introduced and used for the first time as a bone grafting material for GBR. The tooth contents are extremely similar to that of the alveolar bone. The enamel inorganic, organic, and water contents are 95 percent, 0.6 percent, and 4 percent, respectively. However, in the dentin, the percentages are 70 to 75 percent, 20 percent, and 10 percent, respectively. They are 65 percent, 25 percent, and 10 percent, respectively, when compared to the alveolar bone content.

The aim of this study is to compare ridge augmentation using autogenous bone block (ABB) with immediate implant placement and filling the generated gap with autogenous bone graft (ABG) or ATG, or ridge augmentation using xenograft bone block (XBB) with immediate implant placement and filling the generated gap with ATG.

Study Overview

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Kafr Ash Shaykh, Egypt, 33511
        • faculty of dentistry, kafrelsheikh University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Teeth with buccal bone destruction by periodontal disease and need extraction (horizontal or vertical bone defect);
  • Absence of acute inflammation;
  • Absence of uncontrolled systemic illness that would preclude implantation;
  • Good dental and systemic healthy conditions;
  • Patients were willing and able to return for multiple follow-up visits.

Exclusion Criteria:

  • Patients with systemic illnesses,
  • psychological abnormalities,
  • para-functional habit,
  • smokers or alcoholics,
  • pregnant and lactating patients,
  • patients undergoing or recently completed radiotherapy or chemotherapy,
  • patients on drugs affecting the healing process,
  • patients with endodontically treated teeth

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: ABB and ATG with simultaneous implant placement
Using ABB with ATG to fill the gap around simultaneously placed dental implants
Ridge augmentation using ABB and ATG as a graft material with simultaneous implant placement
Experimental: XBB and ATG with simultaneous implant placement
Using XBB with ATG to fill the gap around simultaneously placed dental implants
Ridge augmentation using XBB and ATG as a graft material with simultaneous implant placement
Active Comparator: ABB and ABG with immediate implant
Using ABB with ABG to fill the gap around immediately placed dental implants
Ridge augmentation using ABB and ABG as a graft material with simultaneous implant placement

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical evaluation probing pocket depth and amount of bone around simultaneously placed dental implants
Time Frame: 9 months
Changes on pocket depth and amount of bone using ABG or ATG with ABB or XBB around simultaneously placed dental implants
9 months
radiographic outcome measuring the amount of bone around simultaneously placed dental implants
Time Frame: 9 months
the radiographic outcome by measuring the amount of bone by using ATG or ABG on bone formation with ABB or XBB around simultaneously placed dental implants
9 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Dalia R Issa, PhD, Kafrelsheikh University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2022

Primary Completion (Actual)

August 12, 2023

Study Completion (Actual)

August 20, 2023

Study Registration Dates

First Submitted

April 1, 2022

First Submitted That Met QC Criteria

June 2, 2022

First Posted (Actual)

June 7, 2022

Study Record Updates

Last Update Posted (Actual)

December 22, 2023

Last Update Submitted That Met QC Criteria

December 19, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • KFSIRB200-72

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Implant

Clinical Trials on ABB and ATG with simultaneous implant placement

Subscribe